Skip to main content

U.S. FDA likely to authorize COVID-19 vaccine for kids based on two months of safety data

U.S. heath regulators said children in clinical trials testing COVID-19 vaccines should be monitored for at least two months for side effects, suggesting that the agency is considering a quicker path to authorize more.


Popular posts from this blog